ClinConnect ClinConnect Logo
Search / Trial NCT00004738

Genetic Analysis of the Chiari I Malformation

Launched by NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE (NINDS) · Feb 26, 2000

Trial Information

Current as of July 21, 2025

Completed

Keywords

Arnold Chiari Malformation Skeletal Dysplasia Syringomyelia Genetics Natural History

ClinConnect Summary

Objectives: The goal of this study is to establish family pedigrees and undertake genetic linkage analysis that will identify gene loci associated with the Chiari I malformation and underdevelopment of the bone forming the posterior cranial fossa.

Study Population: Patients and family members of patients with the Chiari I malformation. Because the research institutions are located in the United States and Russia, subjects will be recruited predominantly from these countries.

Design: Human subjects will undergo 1) neurologic examinations, 2) head and cervical MRI scans to evaluate for the ...

Gender

ALL

Eligibility criteria

  • * INCLUSION CRITERIA:
  • To be eligible for entry into the study, a candidate must meet the following criteria:
  • Patient with a confirmed diagnosis of Chiari I malformation who has a family member with syringomyelia or Chiari I malformation, or
  • Family member of a patient with a confirmed diagnosis of Chiari I malformation, AND
  • There are at least two family members diagnosed with Chiari I malformation.
  • If an adult, able to give informed consent; if a minor, has an adult who is legally responsible for the subject and who is able to give consent.
  • EXCLUSION CRITERIA:
  • A candidate will be excluded if he/she:
  • Has a contraindication to MRI scanning.
  • Is unable to comprehend the risks of the testing.
  • Is less than one year of age.
  • Cannot undergo MRI scanning without sedation.

About National Institute Of Neurological Disorders And Stroke (Ninds)

The National Institute of Neurological Disorders and Stroke (NINDS) is a leading component of the National Institutes of Health (NIH), dedicated to advancing our understanding of the brain and nervous system through innovative research. NINDS sponsors and conducts clinical trials aimed at developing effective treatments and improving patient outcomes for a wide range of neurological disorders, including stroke, epilepsy, multiple sclerosis, and neurodegenerative diseases. By fostering collaboration among researchers, healthcare providers, and patient communities, NINDS plays a pivotal role in transforming scientific discoveries into clinical applications, ultimately enhancing the quality of life for individuals affected by neurological conditions.

Locations

Bethesda, Maryland, United States

Bethesda, Maryland, United States

Kazan, , Russian Federation

Patients applied

0 patients applied

Trial Officials

John D Heiss, M.D.

Principal Investigator

National Institute of Neurological Disorders and Stroke (NINDS)

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials